Introduction
Amyloid-b (Ab) peptide is the major component of amyloid deposits and senile plaques of Alzheimer's disease (AD). AD is a complex neurodegenerative condition characterized by decline in cognitive ability, irreversible memory loss and impairment of judgment and reasoning.
1 The neuropathological hallmarks of AD, other than the neurotransmitter depletion of acetylcholine, also include the deposition of two abnormal protein aggregates: intracellularly occurring neurobrillary tangles composed of Tau protein 2 and extracellular insoluble Ab aggregates. 3 The spontaneous conversion of oligomeric Ab into brillar aggregates is associated with the development of AD.
4 Numerous genetic, biochemical and transgenic animal tests supported the "amyloid hypothesis". [5] [6] [7] Currently, more than a hundred drugs are in clinical trials for AD treatment. These mainly consist of neuromodulatory signaling and Ab-related therapies. Out of seven that went to Phase III trials, ve of them were Ab aggregation/clearance targeting drugs. 8 It is therefore feasible to develop novel techniques to study the interaction of Ab with small molecules in the attempt to facilitate drug discovery efforts.
The molecular mechanism of Ab aggregation has been extensively studied, [9] [10] [11] but the exact pathway of misfolding and elongation is still somewhat unclear. It has been hypothesized that the formation of small protein oligomers, which act as nuclei or 'seeds', seems to be a crucial step in the aggregation pathway. 12, 13 This elongation is known as the nucleationdependent polymerization model, 14, 15 which describes that initial unfavorable interactions between oligomers will result in a lag phase, in which stable oligomers are formed. These oligomers then provide nuclei to catalyze further growth of the amyloid, determining a growth phase until the equilibrium between aggregates and oligomers is reached (steady phase).
One strategy to identify promising candidates as amyloid inhibitors is the high-throughput screening of small chemical or natural compounds. Small molecules such as curcumin, 16 rosmarinic acid 17 and various polyphenols 18 have been reported as promising compounds for the inhibition of Ab aggregation. Among these small molecules, (À)-epigallocatechin-3-gallate (EGCG), which is the main polyphenol in green tea, has been reported to modulate the misfolding of prion proteins. [19] [20] [21] [22] In the presence of EGCG, the assembly of a new type of unstructured, non-toxic protein aggregate was observed, suggesting that it promoted the off-pathway oligomeric formation.
23,24
EGCG was therefore, used in this report as a model inhibitor. On the other hand, metal ions such as Fe(III), 25, 26 Cu(II), 27 Zn(II) 28 and Al(III) 29 were shown to generally accelerate the formation of amyloid plaques and reactive oxygen species. It has been found through several reports that Zn(II) could promote amyloid formation under certain conditions. A plethora of techniques have been used to study the aggregation of Ab such as acoustic wave sensors, 33 electrochemistry, 34 atomic force microscopy, 35 total internal reection uorescence microscopy, 36 surface plasmon resonance (SPR), 36, 37 etc. Flavonoids, alkaloids 37 and metals, 38, 39 have also been studied using SPR for their effects on Ab aggregation. 40 We applied the LED-Interferometric Reectance Imaging Sensor (LED-IRIS) for the rst time to study the interaction of Ab with small drug candidates and metal ions (Scheme 1). The technique utilizes common-path interferometry through a Si/SiO 2 layered substrate as the sensing surface to detect local path length changes as a result of mass accumulation with an increase in the spot height at the surface (Fig. S-1 †) . 41 LED-IRIS is a versatile platform, which has been recently applied to detect single nucleotide polymorphisms, DNA hybridization, viral particles and antigen-antibody interactions.
41-45
LED-IRIS provides a high-throughput platform to monitor biomolecular interactions with a low noise oor in real-time. 46 
Experimental section

Chemicals and reagents
Human amyloid-b peptide 1-40 Gln11 (Ab; triuoroacetate salt) <H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-HisHis-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-LysGly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-OH> was obtained from EMD Biosciences (Gibbstown, NJ). Dimethyl sulfoxide (DMSO; 99.99%), 1,1,1,3,3,3-Hexauoro-2-propanol (HFIP, 99.0%), Thioavin T (4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-N,Ndimethylaniline chloride; $75%), sodium phosphate monobasic (NaH 2 PO 4 ; 99.0%) and sodium phosphate dibasic (Na 2 HPO4; 99.0%) were purchased from Sigma-Aldrich (Oakville, ON). Zinc(II) chloride, (À)epigallocatechin-3-gallate (EGCG) and ethanolamine were all obtained from SigmaAldrich Inc. (St. Louis, MO). LED-IRIS chips were prepared on 15 Â 15 mm square silicon substrates with 500 nm thermally grown oxide that were purchased from Silicon Valley Microelectronics (Santa Clara, CA). All samples were prepared in phosphate buffer saline (PBS, 50 mM) with 100 mM NaCl at pH 7.4 using 18.2 MU Milli-Q water. Unless stated otherwise, all reagents were of HPLC quality and purchased from SigmaAldrich (Oakville, ON).
Amyloid pre-treatment
Ab 1-40 was pre-treated by dissolving in HFIP at a ratio of 1 mg : 1 mL. Resulting suspensions were sonicated for 15 min until sample solutions became clear. Ab/HFIP solutions were shaken at 400 rpm for 2 h at 4 AE 1 C. The samples were then le in HFIP and sealed overnight. HFIP was then removed by passing a stream of nitrogen gas across solvent surface, leaving a clear thin lm of peptides at the bottom of the sample vial. The thin lm of peptides were re-constituted in DMSO and mixed by vortex, followed by dilution to the appropriate concentrations with 50 mM PBS with 100 mM NaCl, pH 7.4. Peptide concentrations were determined by measuring the OD at 280 nm using a NanoDrop 2000 (3 280 ¼ 1280 M À1 ) from ThermoScientic (Mississauga, ON).
Surface functionalization
LED-IRIS chips were cleaned by washing extensively using acetone, methanol followed by deionized water prior to functionalization with a coating of N,N-dimethylacrylamideacryloyloxysuccinimide-3(trimethoxysilyl)-propylmethacrylate
Scheme 1 Schematic representation of LED-IRIS system showing the CCD camera, light source and optical components used for illumination of the chip surface. The illumination path consists of two sets of lenses to collect the LED light. The layered Si-SiO 2 substrate was spotted with seeds (incubated under varying modulator conditions) before monomers were introduced to monitor the changes in the spot height in real time.
polymer. 47 The chips were rst activated with 0.1 M NaOH before immersing in the polymer coating (1% w/v polymer in 20% saturated ammonium sulfate solution) for 30 min, then dried with argon before being baked for 15 min at 80 C. The chips were then kept dry in a dessicator until use. The immobilization chemistry utilizes the N-hydroxysuccinimide (NHS) functional groups of the polymer reacting with primary amines on Ab peptides to form covalent bonds.
Real-time monitoring of Ab aggregation
The pretreated Ab peptides were incubated under different conditions at 37 C for 3 h with 300 rpm shaking. The varying conditions included incubating Ab with Zn(II), Ab with EGCG and Ab alone. Aer incubation, the brils were formed in different morphologies. These solutions were sonicated for 5 min to obtain seeds. 48 The NHS-functionalized chips were used directly and the seeds were dispensed by using a desktop spotting unit at 55% chamber humidity (Odyssey Calligrapher microarrayer, BioRad). An aliquot ($0.1 mL) of seed solution was dispensed on the LED-IRIS chip in an array format containing 42 spots (Fig. 1) . To allow complete immobilization of seeds, the chip was incubated at 37 C in a custom made 75% humidity chamber overnight. The LED-IRIS chips were then incubated in 50 mM ethanolamine adjusted to pH 7.4 with shaking for 30 min to deactivate any unreacted NHS groups on the surface. The chips were then washed extensively with PBS-Tween and rinsed briey with water to remove salts. The chips were then dried under an argon stream.
To measure the amyloid growth, each chip was secured in a custom-made ow-cell sealed with a glass window that enabled the optical measurements. Solutions were driven through the ow-cell by using a peristaltic pump at a rate of 100 mL min À1 .
PBS was initially owed through the system to clean and condition the associated tubing and the ow-cell for 30 min. This process also removed any weakly bound seeds before any tests were performed. Ab oligomer solution (5 mM) was then introduced over the seed spots for $5 h. The chip surface was scanned and monitored continuously during the ow of oligomers. All ow-cell experiments were performed at 37 C, which was controlled by a mini-handheld thermo-coupler (Thermoworks, UT) that was in contact with the metallic ow cell. Each spot in the images was then analyzed using the custom-made soware to obtain the optical thickness information (see ESI †). The changes in spot height at each spot was compared to the background by averaging optical thickness information for each pixel within a spot and an annulus outside of the spot and making a direct comparison between those two regions ( Fig. S-2 †) . The analysis of bril formation was performed by subtracting post and pre-incubation images. The accumulation of Ab brils was detected as a change in optical path length at those spots indicating an increase of surface thickness. To nd the relative change in the spot height, the following formula was used:
where S initial and S nal represented the initial and nal measured spot height (nm) of each spot respectively. LED-IRIS has also been calibrated to allow conversion of spot height to mass density of proteins. 45 Therefore, in this study, LED-IRIS signal could also be converted from height (nm) into ng mm À2 .
Cross-seeding study
A cross-seeding study was performed to determine, if bril accumulation was affected by various oligomer seeding conditions. Ab (50 mM) was incubated in the presence and absence of modulators (100 mM Zn(II) or EGCG) for 0, 1, 3 or 5 h to produce the seeds. The seeds were spotted on three LED-IRIS chips using an identical array setup, and le overnight in a humidity chamber as described before. The chips were then deactivated and washed with PBS buffer. Ab (5 mM) oligomers in the presence and absence of modulators (10 mM of Zn(II) and EGCG) were then introduced to their corresponding chip surfaces. Modied chips were incubated with shaking in a small Petridish. PBS-Tween was used to rinse the surface twice to remove the non-specically bound species before a subsequent water rinse to remove salt debris on surfaces. Then, the measurements were performed using the LED-IRIS system as described in the previous section.
Scanning electron microscopy (SEM)
SEM of Ab samples on LED-IRIS chip surfaces was performed using a Hitachi S530 scanning electron microscope (Fig. S-3 †) . Ab samples (100 mM) were incubated at 37 C with 300 rpm shaking in the presence and absence of EGCG (200 mM) or Zn(II) (200 mM). Aer 3 h of incubation, samples were exposed to the LED-IRIS chips. The spots were le to sit overnight to ensure immobilization before rinsing with PBS-Tween and then water as described before. Ab (10 mM) oligomer solution was then incubated on each chip for 16 h before washing with PBS-Tween followed by a quick water rinse. The chips were dried under a stream of nitrogen gas. All LED-IRIS chips were sputtered with Au using the SEM coating unit PS3 (Agar Scientic) at 19 mA plasma current for 100 s. The chips were then electrically connected to the sample stub by smearing graphite paste dissolved in acetone from the sample to the metallic stub. The surfaces of the chips were imaged at an acceleration voltage of 20 kV with a working distance of 5.0 mm.
Results and discussion
Label-free monitoring of amyloid growth
Ab incubated under different conditions resulted in the formation of seeds with varying morphologies. The seeds were then immobilized onto the LED-IRIS chips. The presence of preformed seeds signicantly shortened the lag phase for bril growth. 49 When the oligomers were owed across these spots at a rate of 100 mL s À1 , they were captured by the immobilized seeds, increasing the spot height. Fig. 2A shows the average response of various seed spots aer oligomers were exposed to them. The increase in the signal (optical path length) indicated the rate of bril growth over time ($5 h). A classical sigmoidal curve was observed for the amyloid aggregation process ( Fig. 2A) . The lag phase, however, was shortened to $1 h due to the presence of seeds. This was signicant, compared to the 40 h lag phase of amyloid growth, typically observed in solution based uorescence studies using Thioavin T as reported previously. 40 This was attributed to the bril formation being a nucleation-dependent process. 50 Therefore, the presence of immobilized seeds accelerated the bril growth to a great extent. Fig. 2B shows that the signals (relative height change) for equimolar concentrations (1 : 1) of 100 mM Ab with 100 mM Zn(II) and EGCG were 331 AE 18% and 221 AE 21%, respectively. Ab alone displayed a signal of 267 AE 23%. The data showed that the seeds formed in the presence of Zn(II) resulted in a signi-cantly more bril growth. This was due to the acceleration effect of Zn(II) in amyloid formation that resulted in compact seeds being immobilized on the chip surface compared to Ab alone. When EGCG was incubated with Ab before immobilization, the lowest signal was obtained aer the ow of oligomers. This result was attributed to the interaction of EGCG with Ab, which inhibited its aggregation with oligomers. The effects of modulators could be observed from the signal changes at the spots in real-time. To determine if this effect was concentration-dependent, high concentrations (200 mM) of Zn(II) and EGCG were used during seed incubation. Ab (200 mM) alone was also used in this study as the positive control. Fig. 2B shows that an increase in Ab concentration alone (red) did not signicantly change the signal (283 AE 27%) aer the ow of oligomers. However, when the modulator concentrations were doubled, the signal of Zn(II)-modulated growth increased signicantly (376 AE 20%), while that of EGCG decreased (154 AE 21%) (Fig. S-4 †) . It is also noteworthy that the entire signals recorded using modulator concentrations group were more statistically signicant relative to each other. Therefore, the high concentration ratio was used throughout the subsequent experiments.
Effect of cross-seeding
To determine if the amyloid growth under different seed conditions was affected by different oligomer and modulator conditions, a cross-seeding experiment was performed, where the signals of the spots were monitored intermittently over $15 h (Fig. 3) . In this case, varying oligomeric conditions were used, as well. As shown in Fig. S-5 , † the Ab oligomers with Zn(II) The results implied that the growth of brils was signi-cantly accelerated at Zn(II)-containing seed spots. Negligible bril growth was detected at EGCG-containing seed spots. This was consistent with previous literature, 23 which suggested that amorphous aggregates formed in the presence of EGCG inhibited the aggregation and caused no cytotoxicity, because they were off-pathway aggregarates.
48 Fig. 4 shows the representative changes in signals under various conditions, and it was observed that different conditions exhibited signicant effects on the rate of Ab aggregation.
It was observed that EGCG inhibited the formation of Ab brils both in the presence and absence of Zn(II) in seeds (Fig. 4A) . This was attributed to the weakening of the cross-b structure by the interaction of EGCG with the b-sheets of brils. 51 Interesting to note, the signal decrease was signicant, when Ab with EGCG were exposed to the EGCG-containing seed spots. This implied that the seeds prepared in the presence of EGCG had lower stability compared to other seed conditions, leading to disintegration from chip surface. This was in agreement with the recent literature, where EGCG was shown to break down amyloids into non-toxic off-pathway aggregates.
52-54
When the Ab oligomer incubation contained Zn(II), elongation seemed to persist for the seeds formed in the presence of EGCG (although at a signicantly lower response level compared to other seed conditions) as shown in Fig. 4C . It was proposed by Miller and coworkers 55 that two Zn(II) ions coordinated with residues of two different Ab peptides, facilitating the elongation of brils. Zn(II) binding also decreased the solvation energy for tightly packed oligomers, which stimulated amyloid aggregation. 56 The accelerated formation of amyloids induced by Zn(II) was observed in previous studies. 57, 58 It was also reported that Zn(II) physically bound to Ab peptides by coordinating with histidine residues as conrmed by NMR studies. 59, 60 In parallel to these previous reports, the addition of Ab oligomers in the presence of EGCG to the Zn(II)-bound seeds resulted in a slow increase in bril height, demonstrating that the Zn(II)-containing seeds were not easily disintegrated (Fig. 4C ).
Conclusions
The experiments detailed here indicate that the LED-IRIS platform is a promising platform for high-throughput and real-time detection of protein-small molecule interactions. The highthroughput capability of LED-IRIS is suitable for the screening of novel Ab aggregation modulators that would signicantly accelerate the drug discovery efforts towards AD therapy.
